Cannabis and Acne
Lab evidence exists for CBD; human proof remains absent. Strong treatments already work.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
CBD reduces sebum and inflammation in lab dishes. That's real. But no large clinical trials show it clears acne in people. Most CBD skincare products have never been tested on humans at all. If a product works for your skin, fine — but dermatology already has proven tools (retinoids, benzoyl peroxide) that beat cannabinoids on evidence. Cannabinoid products may help comfort or serve as a backup, but they're not a replacement.
Plain-language summary
Acne develops when excess sebum (skin oil), clogged hair follicles, the bacterium Cutibacterium acnes, and inflammation combine. The skin does have an endocannabinoid system, including in sebaceous glands [1] Strong evidence. In lab experiments, CBD reduced sebum production and suppressed inflammatory markers in cultured human skin cells [2] Strong evidence.
That matters for understanding mechanism, but it is not the same as 'CBD treats acne in people.' Only a handful of small human studies exist, and most CBD skincare products sold today have never been tested in any clinical trial. Marketing has moved faster than evidence.
This article is not medical advice. If you have persistent, painful, or scarring acne, see a dermatologist.
What probably works
In the evidence hierarchy we use: nothing in the cannabis category reaches 'probably works' for acne. There is no cannabinoid product with the repeated, large-scale randomized controlled trial data that support retinoids or benzoyl peroxide [6] Strong evidence.
The closest positive human signal is a small 2015 open-label study of a 3% cannabis seed extract cream applied to the cheeks for 12 weeks, which reported reductions in sebum and skin redness [3] Weak / limited. It was unblinded, enrolled only 20 participants, and has not been replicated. Treat it as a signal worth investigating further, not as proof of efficacy.
What might work
Topical CBD for mild inflammatory acne. The mechanism is plausible: CBD reduced fat production and pro-inflammatory signaling in human sebocytes in culture [2] Strong evidence. Related minor cannabinoids (CBG and CBC) showed similar effects in follow-up studies [4] Weak / limited. None of this has been confirmed in a properly designed and powered randomized human trial. The translation from lab to skin remains unknown.
Hemp seed oil as a non-comedogenic moisturizer. Hemp seed oil contains no meaningful cannabinoids but has a favorable ratio of linoleic to oleic acid; low linoleic acid in sebum is common in acne-prone skin [5] Weak / limited. This is a 'gentle moisturizer' claim, not an acne treatment. It may prevent irritation from other products rather than treat acne itself.
Minor cannabinoids (CBDA, CBN, CBGA). Interesting preclinical data exist, but no human acne trials No data.
What doesn't work or has weak evidence
Smoking or vaping cannabis to clear acne. No evidence supports this. Cannabis use is associated with increased appetite (often for high-glycemic foods, which may worsen acne), disrupted sleep patterns, and variable stress effects — all of which can make acne worse No data.
Oral CBD for acne. No clinical trials exist. Claims here are marketing folklore No data.
CBD for acne scars. Despite confident social media claims, no controlled human studies support cannabinoids improving atrophic (pitted) or hypertrophic (raised) scars No data.
'Full-spectrum' or 'entourage effect' acne serums. The entourage effect itself remains Disputed for most health outcomes, and has zero specific evidence for acne No data.
THC topicals for acne. No human studies exist. Mechanistically, THC may increase sebum production at certain doses in cultured sebocytes, making it less attractive than CBD [2] Weak / limited.
What we don't know
- Optimal CBD concentration. Commercial acne products range from 0.1% to 5%+ CBD with no comparative dose–response data.
- Skin penetration. It is unclear whether CBD penetrates the outer skin layers deeply enough at typical formulations to reach active sebaceous glands in meaningful amounts.
- Interactions with standard treatments. We do not know whether CBD interacts safely or effectively with tretinoin, adapalene, or benzoyl peroxide. Benzoyl peroxide is a powerful oxidizer and likely degrades CBD on contact.
- Long-term safety. Daily topical cannabinoid use on facial skin over months or years has not been systematically studied.
- Systemic effects of oral cannabis on acne. Whether oral cannabis modulates hormones or metabolism in ways that affect acne remains unclear and inconsistent across available data Disputed.
- Individual skin microbiome effects. No studies assess whether cannabinoids alter acne-promoting bacteria in the skin microbiome.
Comparison with standard dermatology treatments
For context, dermatology has established first-line treatments, all with far stronger evidence than any cannabinoid product:
Topical retinoids (tretinoin, adapalene, tazarotene). First-line for most acne types. Decades of randomized controlled trial data support their efficacy [6] Strong evidence. Adapalene 0.1% is available over the counter in the US. They normalize keratin shedding and reduce sebum.
Benzoyl peroxide. Bactericidal against C. acnes with no resistance development documented over 50+ years of use. Strong evidence base [6] Strong evidence.
Topical and oral antibiotics. Effective but used short-term to minimize resistance development [6] Strong evidence.
Hormonal therapy (combined oral contraceptives, spironolactone). Effective for acne driven by androgens; requires appropriate patient selection [7] Strong evidence.
Isotretinoin. Highly effective for severe nodulocystic acne; requires monthly monitoring due to teratogenicity and liver effects [6] Strong evidence.
Cannabinoid products do not currently compete with any of these on evidence. They might serve as adjuncts for skin comfort in patients with irritant dermatitis, or as alternatives for the small subset who cannot tolerate first-line treatments — but that role remains speculative and untested.
Risks and side effects
Topical CBD is generally well tolerated in short-term studies; contact dermatitis is the main adverse event reported [8] Weak / limited. Specific concerns for acne use:
Carrier oils and formulation matter more than the CBD. Many CBD serums use coconut oil (MCT oil), which is comedogenic for a subset of people. Acne may worsen because of the carrier, not the cannabinoid.
Product quality and labeling are unreliable. Independent testing has found CBD products mislabeled by 50% or more in either direction, and some contain pesticide residues or heavy metals [9] Strong evidence. Regulatory oversight of topical CBD remains minimal in most jurisdictions.
Drug interactions are mainly an oral concern. Systemic absorption from topical CBD application is low, but high-dose topical use over large body surface area has not been well studied.
Delayed effective treatment is the largest risk. If moderate-to-severe acne is treated with unproven cannabinoid products instead of proven therapies, the months lost can result in permanent scarring. Acne scarring is largely preventable with early, effective treatment.
This article is not medical advice. Talk to a dermatologist or qualified clinician about your acne and treatment options.
Sources
- Peer-reviewed Bíró T, Tóth BI, Haskó G, Paus R, Pacher P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends in Pharmacological Sciences. 2009;30(8):411–420.
- Peer-reviewed Oláh A, Tóth BI, Borbíró I, et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. Journal of Clinical Investigation. 2014;124(9):3713–3724.
- Peer-reviewed Ali A, Akhtar N. The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content. Pakistan Journal of Pharmaceutical Sciences. 2015;28(4):1389–1395.
- Peer-reviewed Oláh A, Markovics A, Szabó-Papp J, et al. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Experimental Dermatology. 2016;25(9):701–707.
- Peer-reviewed Callaway J, Schwab U, Harvima I, et al. Efficacy of dietary hempseed oil in patients with atopic dermatitis. Journal of Dermatological Treatment. 2005;16(2):87–94.
- Peer-reviewed Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2016;74(5):945–973.
- Peer-reviewed Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database of Systematic Reviews. 2012;(7):CD004425.
- Peer-reviewed Eagleston LRM, Kalani NK, Patel RR, Flaten HK, Dunnick CA, Dellavalle RP. Cannabinoids in dermatology: a scoping review. Dermatology Online Journal. 2018;24(6).
- Peer-reviewed Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 2017;318(17):1708–1709.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and ALS (Amyotrophic Lateral Sclerosis) — Summary of cannabis evidence for ALS symptom management and disease progression.
- Cannabis and Ankylosing Spondylitis — What the evidence actually says about using cannabis for the pain, stiffness, and sleep pr...
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- CBD and Dravet Syndrome — FDA-approved pharmaceutical CBD cuts convulsive seizure frequency by roughly half in Drave...